These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25785582)

  • 1. Cell cycle- and cancer-associated gene networks activated by Dsg2: evidence of cystatin A deregulation and a potential role in cell-cell adhesion.
    Gupta A; Nitoiu D; Brennan-Crispi D; Addya S; Riobo NA; Kelsell DP; Mahoney MG
    PLoS One; 2015; 10(3):e0120091. PubMed ID: 25785582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suprabasal Dsg2 expression in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes.
    Brennan D; Hu Y; Joubeh S; Choi YW; Whitaker-Menezes D; O'Brien T; Uitto J; Rodeck U; Mahoney MG
    J Cell Sci; 2007 Mar; 120(Pt 5):758-71. PubMed ID: 17284515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmoglein 2 is less important than desmoglein 3 for keratinocyte cohesion.
    Hartlieb E; Kempf B; Partilla M; Vigh B; Spindler V; Waschke J
    PLoS One; 2013; 8(1):e53739. PubMed ID: 23326495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A molecular study of desmosomes identifies a desmoglein isoform switch in head and neck squamous cell carcinoma.
    Teh MT; Parkinson EK; Thurlow JK; Liu F; Fortune F; Wan H
    J Oral Pathol Med; 2011 Jan; 40(1):67-76. PubMed ID: 20923451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for caveolin-1 in desmoglein binding and desmosome dynamics.
    Brennan D; Peltonen S; Dowling A; Medhat W; Green KJ; Wahl JK; Del Galdo F; Mahoney MG
    Oncogene; 2012 Mar; 31(13):1636-48. PubMed ID: 21841821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes.
    Overmiller AM; Pierluissi JA; Wermuth PJ; Sauma S; Martinez-Outschoorn U; Tuluc M; Luginbuhl A; Curry J; Harshyne LA; Wahl JK; South AP; Mahoney MG
    FASEB J; 2017 Aug; 31(8):3412-3424. PubMed ID: 28438789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desmoglein 2 compensates for desmoglein 3 but does not control cell adhesion via regulation of p38 mitogen-activated protein kinase in keratinocytes.
    Hartlieb E; Rötzer V; Radeva M; Spindler V; Waschke J
    J Biol Chem; 2014 Jun; 289(24):17043-53. PubMed ID: 24782306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in CSTA, encoding Cystatin A, underlie exfoliative ichthyosis and reveal a role for this protease inhibitor in cell-cell adhesion.
    Blaydon DC; Nitoiu D; Eckl KM; Cabral RM; Bland P; Hausser I; van Heel DA; Rajpopat S; Fischer J; Oji V; Zvulunov A; Traupe H; Hennies HC; Kelsell DP
    Am J Hum Genet; 2011 Oct; 89(4):564-71. PubMed ID: 21944047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk between Desmoglein 2 and Patched 1 accelerates chemical-induced skin tumorigenesis.
    Brennan-Crispi DM; Hossain C; Sahu J; Brady M; Riobo NA; Mahoney MG
    Oncotarget; 2015 Apr; 6(11):8593-605. PubMed ID: 25871385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of desmoglein 2 promotes tumorigenic behavior in pancreatic cancer cells.
    Hütz K; Zeiler J; Sachs L; Ormanns S; Spindler V
    Mol Carcinog; 2017 Aug; 56(8):1884-1895. PubMed ID: 28277619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of Dsg2 in malignant skin carcinomas: A tissue-microarray based study.
    Brennan D; Mahoney MG
    Cell Adh Migr; 2009; 3(2):148-54. PubMed ID: 19458482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acral peeling skin syndrome associated with a novel CSTA gene mutation.
    Muttardi K; Nitoiu D; Kelsell DP; O'Toole EA; Batta K
    Clin Exp Dermatol; 2016 Jun; 41(4):394-8. PubMed ID: 26684698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desmoglein 2-Dependent Arrhythmogenic Cardiomyopathy Is Caused by a Loss of Adhesive Function.
    Kant S; Holthöfer B; Magin TM; Krusche CA; Leube RE
    Circ Cardiovasc Genet; 2015 Aug; 8(4):553-63. PubMed ID: 26085008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2.
    Cai F; Zhu Q; Miao Y; Shen S; Su X; Shi Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):59-69. PubMed ID: 27629878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dsg2 Upregulation as a Rescue Mechanism in Pemphigus.
    Sigmund AM; Steinert LS; Egu DT; Bayerbach FC; Waschke J; Vielmuth F
    Front Immunol; 2020; 11():581370. PubMed ID: 33193387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The most widespread desmosomal cadherin, desmoglein 2, is a novel target of caspase 3-mediated apoptotic machinery.
    Cirillo N; Lanza M; De Rosa A; Cammarota M; La Gatta A; Gombos F; Lanza A
    J Cell Biochem; 2008 Feb; 103(2):598-606. PubMed ID: 17559062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay of ERα binding and DNA methylation in the intron-2 determines the expression and estrogen regulation of cystatin A in breast cancer cells.
    John Mary DJS; Sikarwar G; Kumar A; Limaye AM
    Mol Cell Endocrinol; 2020 Mar; 504():110701. PubMed ID: 31926189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR and ADAMs cooperate to regulate shedding and endocytic trafficking of the desmosomal cadherin desmoglein 2.
    Klessner JL; Desai BV; Amargo EV; Getsios S; Green KJ
    Mol Biol Cell; 2009 Jan; 20(1):328-37. PubMed ID: 18987342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Src/Cav1-dependent activation of the EGFR by Dsg2.
    Overmiller AM; McGuinn KP; Roberts BJ; Cooper F; Brennan-Crispi DM; Deguchi T; Peltonen S; Wahl JK; Mahoney MG
    Oncotarget; 2016 Jun; 7(25):37536-37555. PubMed ID: 26918609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of Cutaneous Wound Healing by Dsg2 Augmentation of uPAR Secretion.
    Cooper F; Overmiller AM; Loder A; Brennan-Crispi DM; McGuinn KP; Marous MR; Freeman TA; Riobo-Del Galdo NA; Siracusa LD; Wahl JK; Mahoney MG
    J Invest Dermatol; 2018 Nov; 138(11):2470-2479. PubMed ID: 29753032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.